Dihydroberberine 483-15-8

Product Details
Customization: Available
Certification: ISO
Assay Method: HPLC
Still deciding? Get samples of US$ 1008/kg
Request Sample
Manufacturer/Factory

360° Virtual Tour

Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters
The supplier has import and export rights
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Experienced Team
The supplier has 6 foreign trading staff(s) and 3 staff(s) with over 6 years of overseas trading experience
Patents Awarded
The supplier had awarded 1 patents, you can check the Audit Report for more information
to see all verified strength labels (11)
  • Dihydroberberine 483-15-8
  • Dihydroberberine 483-15-8
  • Dihydroberberine 483-15-8
  • Dihydroberberine 483-15-8
  • Dihydroberberine 483-15-8
  • Dihydroberberine 483-15-8
Find Similar Products
  • Overview
  • Application
  • Packaging & Shipping
Overview

Basic Info.

Model NO.
2024333
Transport Package
Drum
Specification
box
Trademark
gm5
Origin
Jiangsu, Shaanxi, Beijing
HS Code
20240
Production Capacity
800ton/Year

Product Description


Dihydroberberine inhibits the human ether-associated gene (hERG) channel, significantly reducing the expression of heat shock protein 90(Hsp90) and its interaction with hERG. Dihydroberberine has anti-inflammatory, anti-atherogenic, hypolipidemic and anti-tumor activities.


 

DHB exerts its uric acid-lowering effect by inhibiting the activation of XOD, URAT1, GLUT9, and NLRP3 inflammatory vesicles in the kidneys, and is renoprotective in addition to being antihyperuricemic.
The treatment of DHB had a protective effect on renal function.
These results suggest that DHB ameliorates renal injury and has a nephroprotective effect in HUA mice.
DHB showed XOD enzyme inhibition in a concentration-dependent manner.DHB significantly inhibited XOD activity (Figure 4D). This result suggests that DHB has an inhibitory effect on XOD.
Treatment with DHB was effective in ameliorating PO/HX-induced renal inflammation.
DHB showed the ability to inhibit XOD activity both in vitro and in vivo.
And the treatment of DHB also showed significant inhibition of renal URAT1 and GLUT9 levels.
Thus, DHB was able to reduce urate formation by inhibiting hepatic XOD while down-regulating renal URAT1 and GLUT9 to enhance urate excretion, suggesting a dual anti-hyperuricemic effect.
In addition, the mechanism by which DHB exerts its renoprotective effects was found to be through the inhibition of NLRP3 inflammasome activation to attenuate renal inflammation and dysfunction.

 
 

Application

Health Care Products, Food, Daily Necessities, Cosmetics, Functional Drink
 

Packaging & Shipping

 

Package
1kg/bag ,25kg/bag;25kg/drum; customize as customer's equirements.
Transit
Fedex, TNT,DHL,EMS,and so on.
Shipping port
Shanghai/Tianjin/Dalian/Beijing/Xi'an
Lead Time
1-2 working days upon received the payment
For mass orders, it will be delivered by air or sea.
Depending on your location, please allow 1-5 business days for your order to arrive.
For small order, please expect 3-7 days by UPS DHL EMS.
For mass order, please allow 5-8 days by Air, 15-30 days by Sea.





Dihydroberberine 483-15-8Dihydroberberine 483-15-8Dihydroberberine 483-15-8Dihydroberberine 483-15-8Dihydroberberine 483-15-8Dihydroberberine 483-15-8Dihydroberberine 483-15-8Dihydroberberine 483-15-8Dihydroberberine 483-15-8





 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier